Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
0 hedge funds and large institutions have $0 invested in Augmedix, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 44 closing their positions.
100% less funds holding
Funds holding: 45 → 0 (-45)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $84.4M → $0 (-$84.4M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 44
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$38.5M |
| 2 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$10.6M |
| 3 |
OBAM
ODDO BHF Asset Management
Paris,
France
|
-$5.7M |
| 4 |
SM
Samjo Management
New York
|
-$4.23M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.73M |
AUGX Hedge Fund Activity: Q4 2024 in Review
0 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q4 2024, worth a combined $0 — down 100% from $84.4M a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of AUGX and 0 opened new positions — a net loss of 44 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Redmile Group, exiting entirely with an estimated $38.5M sold.
- 0 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q4 2024, down from 45 in Q3 2024.
- Funds reported $0 of Augmedix, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
- 0 funds opened new Augmedix, Inc. Common Stock positions in Q4 2024 and 44 closed out, a net change of -44 holders.
- The largest Augmedix, Inc. Common Stock seller in Q4 2024 was Redmile Group, an estimated $38.5M sold.
Based on aggregated 13F filings for Q4 2024.